The Discounted Cash Flow (DCF) valuation of Telcon RF Pharmaceutical Inc (200230.KQ) is (3,200.69) KRW. With the latest stock price at 3,305.00 KRW, the upside of Telcon RF Pharmaceutical Inc based on DCF is -196.8%.
Based on the latest price of 3,305.00 KRW and our DCF valuation, Telcon RF Pharmaceutical Inc (200230.KQ) is a sell. selling 200230.KQ stocks now will result in a potential gain of 196.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 8.6% | 6.6% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (3,415.34) - (3,191.95) | (3,200.69) |
| Upside | -203.3% - -196.6% | -196.8% |